Medpace
MEDP
604.25
+1.35
+0.22%
Medpace
US · MEDP
#1015 by market cap
Listed 2016
604.25
+1.35
+0.22%
Live - 5344 symbols - heartbeat 549s ago
· 2026-10-08 07:38
Pre-market
604.25
0.00%
After-hours
604.25
0.00%
Overnight
604.25
0.00%
- Market cap
- 16.87B
- P/E (TTM)i
- 35.50
- P/Bi
- 38.87
- EPSi
- 15.28
- Div yieldi
- 0.00%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on MEDP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.3 percentage points.
Institutional ownership
- Held by institutions
- 89.63% -0.29pp
- Institutions
- 831 -6
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund72.42%
Individual/Insider18.93%
Hedge Fund7.86%
Public Company4.88%
Government Pension Fund2.18%
Private Company0.85%
Sovereign Wealth Fund0.82%
Family Office/Trust0.35%
Insurance Company0.18%
Top holders as of 2026-09-24
August Troendle
18.35% · 5.12M sh
BlackRock
8.95% · 2.50M sh
T. Rowe Price Group, Inc.
7.42% · 2.07M sh
AQR Capital Management
4.55% · 1.27M sh
Vanguard Capital Management, LLC
4.20% · 1.17M sh
Vanguard Portfolio Management, LLC
4.06% · 1.13M sh
State Street Global Advisors
2.55% · 710.90K sh
Geode Capital Management, LLC
2.55% · 710.47K sh
Wasatch Advisors LP
2.28% · 636.60K sh
Invesco Capital Management LLC
1.82% · 508.78K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 23 buys · 24 sells
| Name | Role | Stake |
|---|---|---|
| August Troendle | Chairperson & CEO | 18.35% |
| Susan Burwig | Officer | 0.24% |
| Brian Carley | Independent Director | 0.10% |
| Stephen Ewald | Chief Compliance Officer, General Counsel & Corporate Secretary | 0.07% |
| Jesse Geiger | President | 0.05% |
| Kevin Brady | Chief Financial Officer | 0.05% |
| Cornelius McCarthy | Independent Director | 0.04% |
| Fred Davenport | Lead Independent Director | 0.02% |
| Robert Kraft | Independent Director | 0.00% |
| Brad Hansman | Officer | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Cornelius McCarthy | Independent Director | Derivative Exercise and Retained | +28 | -- |
| 2026-09-29 | August Troendle | Chairperson & CEO | Open Market Disposition | -48,667 | $621.02–625.47 |
| 2026-09-29 | Robert Kraft | Independent Director | Derivative Exercise and Retained | +32 | -- |
| 2026-09-29 | Brian Carley | Independent Director | Derivative Exercise and Retained | +36 | -- |
| 2026-09-27 | August Troendle | Chairperson & CEO | Open Market Disposition | -2,564 | $620.07–620.60 |
| 2026-09-23 | August Troendle | Chairperson & CEO | Open Market Disposition | -43,916 | $621.33–628.64 |
| 2026-09-21 | August Troendle | Chairperson & CEO | Open Market Disposition | -70,901 | $623.29–628.11 |
| 2026-09-16 | August Troendle | Chairperson & CEO | Open Market Disposition | -10,880 | $620.40 |
| 2026-09-15 | August Troendle | Chairperson & CEO | Open Market Disposition | -24,741 | $620.84–621.29 |
| 2026-09-14 | Susan Burwig | Officer | Derivative Exercise and Retained | +3,000 | $166.73 |
| 2026-08-26 | August Troendle | Chairperson & CEO | Open Market Disposition | -650 | $620.27 |
| 2026-08-25 | August Troendle | Chairperson & CEO | Open Market Disposition | -4,673 | $620.03–620.38 |
| 2026-08-25 | Robert Kraft | Independent Director | Derivative Exercise and Sale | -3,858 | $84.36–617.81 |
| 2026-08-23 | August Troendle | Chairperson & CEO | Open Market Disposition | -15,978 | $620.23–624.45 |
| 2026-08-19 | August Troendle | Chairperson & CEO | Open Market Disposition | -42,783 | $606.47–618.79 |
| 2026-08-19 | Kevin Brady | Chief Financial Officer | Derivative Exercise and Sale | -3,400 | $138.87–625.24 |
| 2026-08-18 | Fred Davenport | Lead Independent Director | Derivative Exercise and Sale | -7,283 | $84.36–606.15 |
| 2026-08-18 | Fred Davenport | Lead Independent Director | Derivative Exercise and Retained | +300 | $133.87 |
| 2026-08-18 | Brian Carley | Independent Director | Open Market Disposition | -5,000 | $608.63 |
| 2026-08-12 | August Troendle | Chairperson & CEO | Open Market Disposition | -11,824 | $600.39–601.53 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:38:54 · For reference only, not investment advice and not tailored to your situation.